Skip to main content
TipRanks
Go Ultimate75% OFF

Martin J Duvall Insider Profile

4 Followers

Martin J Duvall, Chief Executive Officer at Oncopeptides AB, holds 8.80K shares in Oncopeptides AB (Ticker: SE:ONCO). Most recently, Martin J Duvall Bought 800 shares of Oncopeptides AB on Dec 03, 2020 for an estimated value of kr128.08K.

Martin J Duvall's Trading History

ONCO
Oncopeptides AB
Dec 03, 2020Chief Executive OfficerInformative Buy128.08Kkr15.58K
SE:ONCO
Insider Shares: 8.80K (1.30%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Dec 03, 2020Informative Buykr128.08K800kr160.10-94.30%―
Sep 15, 2020Informative Buykr1.07M8,000kr133.90-68.80%―

You May Also Like

Martin J Duvall insider profile FAQ

What is the percentage of profitable transactions made by Martin J Duvall?
The percentage of profitable transactions made by Martin J Duvall is 0%.
What is the average return per transaction made by Martin J Duvall?
The average return per transaction made by Martin J Duvall is -81.50%.
What stocks does Martin J Duvall hold?
Martin J Duvall holds: SE:ONCO stocks.
What was Martin J Duvall’s latest transaction?
Martin J Duvall’s latest transaction was an Informative Buy of kr128.08K.
What was Martin J Duvall's most profitable transaction?
Martin J Duvall’s most profitable transaction was an Informative Buy of SE:ONCO stock on September 15, 2020. The return on the trade was -68.80%.
What is Martin J Duvall's role in Oncopeptides AB?
Martin J Duvall's role in Oncopeptides AB is Chief Executive Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.